Cognex Corp: Form 10-Q for the period ended Oct 3, 2021
Filed with the SEC on Nov 4, 2021 and accepted by EDGAR at Nov 4, 2021, 16:08 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-10-03. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-07-05 to 2021-10-03 | $284.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2021-01-01 to 2021-10-03 | $793.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-07-05 to 2021-10-03 | $85.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2021-01-01 to 2021-10-03 | $208.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-07-05 to 2021-10-03 | $199.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2021-01-01 to 2021-10-03 | $584.8m | us-gaap:GrossProfit |
| Research and development | 3 months2021-07-05 to 2021-10-03 | $34.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-01-01 to 2021-10-03 | $99.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-07-05 to 2021-10-03 | $77.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2021-01-01 to 2021-10-03 | $226.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-07-05 to 2021-10-03 | $87.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-10-03 | $258.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-07-05 to 2021-10-03 | $9.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-01-01 to 2021-10-03 | $34.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-07-05 to 2021-10-03 | $78.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-01-01 to 2021-10-03 | $226.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-07-05 to 2021-10-03 | $0.44 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-01-01 to 2021-10-03 | $1.26 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2021-07-05 to 2021-10-03 | 180,342,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-01-01 to 2021-10-03 | 180,109,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-01-01 to 2021-10-03 | $258.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-01-01 to 2021-10-03 | $10.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2021-01-01 to 2021-10-03 | $31.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2021-01-01 to 2021-10-03 | $48.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-10-03 | $203.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-10-03 | $672.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-10-03 | $2.05bn | us-gaap:Assets |
| Current liabilities | At period end2021-10-03 | $165.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-10-03 | $555.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-10-03 | $1.49bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2021-10-03 | 176,799,003 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000851205-21-000024. Last ingested by Listed: Nov 10, 2026, 23:02 ET. Listed shows no prices and gives no investment advice.